Reversing Diabetes Through New miRNA Drugs

Diabetes: Silent Killer

Diabetes Complications
Diabetes (type 2 diabetes: T2D) is a silent killer—the disease can be present for years before a diagnosis is made. About 1.4 million new cases of diabetes are diagnosed in the United States every year. Blood glucose is fairly easily controlled by medication, but this does not prevent the long-term complications. Despite blood glucose control, damage occurs to virtually every organ system.

Limitations of Current Anti-Diabetic Drugs

Insulin Glucose

Diabetes: Silent Killer

Reverse metabolic diseases using natural anti-diabetic and anti-obesity microRNAs
miRNA Treatment
miRNA flow chart

How It Works

miRNAs change gene expression, cell phenotype and function
We have discovered anti-diabetic and anti-obesity miRNAs that act on pancreatic cells, fat cells and gastrointestinal cells to reverse the pathology of type 2 diabetes.

Diabetic Therapeutic Pipeline

Lead identification:

RSVI-301/302 are anti-diabetic and anti-obese miRNAs